Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A7CO
|
|||
| Drug Name |
Heparin
|
|||
| Synonyms |
enoxaparin; Ardeparin; Bemiparin; SEMULOPARIN; Lovenox; LMWH; Nadroparin; Nadroparine; Reviparin; Clivarin; Sublingula; Sandoparin; Parvoparin; Parnaparin; Novoheparin; Adomiparin; Tinzaparin; Multiparin; Hepathrom; Heparina; Triofiban; Pularin; Liquemin; Heparinum; Subeparin; PK-10169; Pabyrin; Octaparin; Liquaemin; Heparine; Vetren; Fluxum; Hed-heparin; Depo-Heparin; Lipo-hepin; Fragmin A; Fragmin B; Vitrum AB; Heparin [BAN]; Eparina [DCIT]; CY 216; Adomiparin [USAN]; FR 860; Heparin CY 216; Heparine [INN-French]
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Venous thrombosis [ICD-11: BA43; ICD-10: I24.0] | Approved | [1] | |
| Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Investigative | [2] | ||
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C26H42N2O37S5
|
|||
| Canonical SMILES |
CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O
|
|||
| InChI |
1S/C26H42N2O37S5/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)
|
|||
| InChIKey |
HTTJABKRGRZYRN-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 9005-49-6
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 090809. | |||
| REF 2 | Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020 Dec;9(1):727-732. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.